In recognition of their extraordinary $3 million donation, the future Hôpital Maisonneuve-Rosemont integrated cancer centre will be named after Sandra and Alain Bouchard.
19 April 2018
Alain Bouchard, fondateur d’Alimentation Couche-Tard inc., Lucie Drapeau, directrice générale de la Fondation HMR, Dr Denis-Claude Roy, Sandra Chartrand, présidente de la Fondation Sandra et Alain Bouchard, Pierre Nelis, président du conseil d’administration de la Fondation HMR, et Yvan Gendron, président-directeur général du CIUSSS de l’Est-de-l’île-de-Montréal.
Montréal, April 17, 2018 – On Monday, April 16th, in front of family members and guests from the business and healthcare communities, the Hôpital Maisonneuve-Rosemont Foundation celebrated the outstanding generosity of Sandra Chartrand and Alain Bouchard. Inspired by the countless possibilities offered by cellular therapy, the couple donated $3 million, through their foundation, to support cutting-edge cancer research at the HMR. In recognition of this exemplary donation, the HMR Foundation announced that the future Integrated Cancer Centre will be named after them.
The Sandra and Alain Bouchard Integrated Cancer Centre will be the only centre of its kind in Québec to offer cellular therapy treatment, harnessing the body’s natural ability to heal itself. “A veritable medical revolution is underway at the HMR and we are very proud to contribute to this, said Alain Bouchard, Founder and Executive Chairman of the Board, Alimentation Couche-Tard Inc. Supporting this cutting-edge cancer research enables us to provide hope to the many patients who will benefit from these phenomenal advances.”
Indeed, this major donation will have a direct impact on clinical research, for patients suffering from cancer. “For us, giving is a responsibility. We feel it is vitally important to facilitate access to cutting-edge therapies in Québec. Knowing that our donation will have a direct impact on developing better patient care brings us the greatest satisfaction,” added Sandra Chartrand, President of the Sandra and Alain Bouchard Foundation.
The future HMR Integrated Cancer Centre: Dominique Michel’s cause
For the past six years, Dominique Michel, who was successfully treated for cancer at the HMR, has mobilized her friends from the entertainment world, members of the business community and the general public to raise the funds needed for the construction of the future HMR Integrated Cancer Centre.
The cost of the Integrated Cancer Centre is estimated à $80 million, $12 million of which will be provided by the HMR Foundation and its donors. The Centre will be appointed with ultramodern equipment and facilities in order to meet the growing needs more effectively. A veritable human and medical breakthrough, it will place the patient at the heart of all types of care.
“I am deeply touched by Sandra and Alain Bouchard’s immense generosity, stated HMR Foundation ambassador Dominique Michel. This invaluable support will enable our researchers to make giant strides in the development of revolutionary cancer treatments. Thank you so much!”
About the HMR Foundation
As a key partner for the past 40 years, the HMR Foundation has supported the Hôpital Maisonneuve-Rosemont (HMR) in its strategic development orientations in order to respond more effectively to patient needs. Deeply committed to making a difference, the Foundation supports projects focusing on the ongoing improvement of patient care, the development of teaching and the expansion of research. The Foundation solicits the financial support of individual donors, private foundations, partners and corporations. Collectively, they recognize the excellence of care provided to patients at the HMR, an outstanding hospital centre affiliated with the Université de Montréal.
